Akari Logo (1).jpg
Akari Therapeutics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day
January 27, 2016 07:30 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that members of its...
Akari Logo (1).jpg
Akari Therapeutics Announces Additional Data from Non-Human Primate Safety Study Demonstrating Equivalent Coversin Efficacy in Both Elisa CH50 and Hemolytic SRBC Assays
January 05, 2016 07:05 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced an update from its 28 day...
Akari Logo (1).jpg
Akari Therapeutics Announces Update From Non-Human Primate Safety Study at International PNH Interest Group 10th Annual Scientific Meeting
December 07, 2015 07:30 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, provided an update from its 28 day...
Akari Logo (1).jpg
Akari Therapeutics Announces Upcoming Data Presentations at the 57th American Society of Hematology Annual Meeting
November 05, 2015 09:44 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that new data on...
Akari Logo (1).jpg
Akari Therapeutics Closes $75 Million Private Placement
September 21, 2015 07:15 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Akari Therapeutics (formerly known as Celsus Therapeutics plc) (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical...
Akari Logo (1).jpg
Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
September 18, 2015 07:31 ET | Akari Therapeutics Plc
NEW YORK and LONDON, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Celsus Therapeutics Plc (NASDAQ:CLTX) and Volution Immuno Pharmaceuticals SA today announced that, following shareholder approval obtained...